| abstract |
The present invention relates to antibodies, including human antibodies, and their antigen-binding parts that bind to P-cadherin and which function by inhibiting P-cadherin. The invention also relates to the heavy and light chains of immunoglobulins derived from antibodies against human P-cadherin, and to nucleic acid molecules that encode such immunoglobulins. The present invention also relates to methods for producing antibodies against human P-cadherin, compositions containing such antibodies, and methods for using antibodies and compositions. The invention also relates to transgenic animals or plants containing nucleic acid molecules of the present invention. |